Skip to main content
. 2021 Oct 28;17(1):e202100576. doi: 10.1002/cmdc.202100576

Figure 18.

Figure 18

Structures from WO 2017/114509. (a) general scaffold; (b–f) most potent exemplified inhibitors against SARS‐CoV 3CLpro.